• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

静脉注射阿奇霉素引起的耳毒性。

Intravenous azithromycin-induced ototoxicity.

作者信息

Bizjak E D, Haug M T, Schilz R J, Sarodia B D, Dresing J M

机构信息

College of Pharmacy, University of Arizona, USA.

出版信息

Pharmacotherapy. 1999 Feb;19(2):245-8. doi: 10.1592/phco.19.3.245.30930.

DOI:10.1592/phco.19.3.245.30930
PMID:10030778
Abstract

Intravenous azithromycin is increasingly administered for treatment of hospitalized patients with community-acquired pneumonia. Macrolide antibiotics cause ototoxicity, which occurs most frequently when high serum concentrations are achieved. Current dosing guidelines for intravenous azithromycin can result in much higher serum concentrations than is seen with oral administration. We describe a 47-year-old woman who developed complete deafness after receiving 8 days of intravenous azithromycin.

摘要

静脉注射阿奇霉素越来越多地用于治疗社区获得性肺炎的住院患者。大环内酯类抗生素会导致耳毒性,在血清浓度较高时最常发生。目前静脉注射阿奇霉素的给药指南可能导致血清浓度比口服给药时高得多。我们描述了一名47岁女性,在接受8天静脉注射阿奇霉素后出现完全性耳聋。

相似文献

1
Intravenous azithromycin-induced ototoxicity.静脉注射阿奇霉素引起的耳毒性。
Pharmacotherapy. 1999 Feb;19(2):245-8. doi: 10.1592/phco.19.3.245.30930.
2
Contradiction between in vitro and clinical outcome: intravenous followed by oral azithromycin therapy demonstrated clinical efficacy in macrolide-resistant pneumococcal pneumonia.体外结果与临床结果相矛盾:在耐大环内酯类肺炎链球菌肺炎中,静脉注射后接着口服阿奇霉素治疗显示出了临床疗效。
J Infect Chemother. 2014 Mar;20(3):199-207. doi: 10.1016/j.jiac.2013.10.010. Epub 2013 Dec 11.
3
Comparative study of the efficacy and tolerance of azithromycin versus clarithromycin in the treatment of community-acquired pneumonia in adults.阿奇霉素与克拉霉素治疗成人社区获得性肺炎的疗效及耐受性比较研究
J Chemother. 2004 Feb;16(1):102-3. doi: 10.1179/joc.2004.16.1.102.
4
Azithromycin is not associated with QT prolongation in hospitalized patients with community-acquired pneumonia.阿奇霉素与社区获得性肺炎住院患者的QT间期延长无关。
Pharmacoepidemiol Drug Saf. 2015 Oct;24(10):1042-8. doi: 10.1002/pds.3842. Epub 2015 Aug 2.
5
Efficacy and safety of intravenous azithromycin followed by oral azithromycin for the treatment of acute pelvic inflammatory disease and perihepatitis in Japanese women.静脉注射阿奇霉素继以口服阿奇霉素治疗日本女性急性盆腔炎和肝周炎的疗效及安全性
J Infect Chemother. 2014 Jul;20(7):429-35. doi: 10.1016/j.jiac.2014.04.001. Epub 2014 Apr 29.
6
Irreversible sensorineural hearing loss as a result of azithromycin ototoxicity. A case report.阿奇霉素耳毒性导致的不可逆性感音神经性听力损失。一例病例报告。
Ann Otol Rhinol Laryngol. 2000 Apr;109(4):435-7. doi: 10.1177/000348940010900416.
7
Pharmacokinetics and tissue tolerance of azithromycin after intramuscular administration to rabbits.阿奇霉素对家兔肌肉注射后的药代动力学及组织耐受性
Res Vet Sci. 2006 Dec;81(3):366-72. doi: 10.1016/j.rvsc.2006.01.006. Epub 2006 Mar 10.
8
An Italian experience of sequential intravenous and oral azithromycin plus intravenous ampicillin/sulbactam in hospitalized patients with community-acquired pneumonia.意大利一项关于住院社区获得性肺炎患者序贯静脉及口服阿奇霉素联合静脉注射氨苄西林/舒巴坦的研究经验。
J Chemother. 2008 Apr;20(2):225-32. doi: 10.1179/joc.2008.20.2.225.
9
Clinical and bacteriological outcomes in hospitalised patients with community-acquired pneumonia treated with azithromycin plus ceftriaxone, or ceftriaxone plus clarithromycin or erythromycin: a prospective, randomised, multicentre study.阿奇霉素联合头孢曲松、或头孢曲松联合克拉霉素或红霉素治疗社区获得性肺炎住院患者的临床和细菌学转归:一项前瞻性、随机、多中心研究
Clin Microbiol Infect. 2007 Feb;13(2):162-171. doi: 10.1111/j.1469-0691.2006.01633.x.
10
Intravenous azithromycin.静脉注射阿奇霉素。
Ann Pharmacother. 1999 Feb;33(2):218-28. doi: 10.1345/aph.18046.

引用本文的文献

1
Cystic Fibrosis Foundation otolaryngology care multidisciplinary consensus recommendations.囊性纤维化基金会耳鼻喉科多学科护理共识建议。
Int Forum Allergy Rhinol. 2022 Sep;12(9):1089-1103. doi: 10.1002/alr.22974. Epub 2022 Feb 22.
2
Ototoxicity of Non-aminoglycoside Antibiotics.非氨基糖苷类抗生素的耳毒性
Front Neurol. 2021 Mar 9;12:652674. doi: 10.3389/fneur.2021.652674. eCollection 2021.
3
What the dental practitioner needs to know about pharmaco-therapeutic modalities of COVID-19 treatment: A review.牙科从业者需要了解的关于COVID-19治疗的药物治疗方式:综述。
J Dent Sci. 2021 Jul;16(3):806-816. doi: 10.1016/j.jds.2020.11.007. Epub 2020 Nov 19.
4
COVID-19: Present and Future Challenges for Dental Practice.新冠疫情:牙科实践的当前和未来挑战。
Int J Environ Res Public Health. 2020 Apr 30;17(9):3151. doi: 10.3390/ijerph17093151.
5
Macrolides: A Canadian Infectious Disease Society position paper.大环内酯类药物:加拿大传染病协会立场文件。
Can J Infect Dis. 2001 Jul;12(4):218-31. doi: 10.1155/2001/657353.
6
Review of macrolides and ketolides: focus on respiratory tract infections.大环内酯类和酮内酯类药物综述:聚焦呼吸道感染
Drugs. 2001;61(4):443-98. doi: 10.2165/00003495-200161040-00003.